Author: Bureau

INDO-MIM Limited has announced that its initial public offering (IPO) will open for subscription on Thursday, July 23, 2026, with the anchor investor bidding scheduled for Wednesday, July 22, 2026. The issue will close on Monday, July 27, 2026. The company has fixed the price band at ₹461 to ₹485 per equity share of face value ₹1 each. Investors can bid for a minimum of 30 equity shares and in multiples of 30 shares thereafter. The IPO comprises a fresh issue of equity shares aggregating up to ₹5,000 million and an Offer for Sale (OFS) of up to 68.29 million…

Emcure Pharmaceuticals Limited today announced that Poviztra®, its co-marketed brand of innovator semaglutide (rDNA origin), will now be available for the treatment of non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (F2-F3), following the Central Drugs Standard Control Organization’s (CDSCO) approval of Wegovy® for this indication. The approval enables Emcure to offer the new indication through Poviztra®, expanding access to the innovator molecule from Novo Nordisk, the first and only GLP-1 receptor agonist approved in India for the treatment of MASH. The therapy is manufactured at Novo Nordisk’s European facility and imported into India. MASH…

OptraSCAN, Inc., a California-headquartered digital pathology and image analysis company in which Molbio Diagnostics Limited acquired a majority stake in 2025, has received U.S. Food and Drug Administration (FDA) 510(k) clearance (K260755) for its integrated OptraSCAN System. The clearance covers the OS-Ultra Whole Slide Scanner, a colour display monitor and a workstation running ImagePath Image Management Software, including HER2 Image Analysis Software, enabling pathologists to review and assess HER2 expression in clinical practice. HER2 assessment is an important component of breast cancer diagnosis and helps guide treatment decisions. With pathology laboratories increasingly adopting digital workflows, image analysis technologies are playing…

Takeda Biopharmaceuticals India Pvt. Ltd. has received market authorization from the Drug Controller General of India (DCGI) for QDENGA, making it the first dengue vaccine approved in India for the prevention of dengue in individuals aged 4–60 years. The vaccine can be administered without prior dengue screening, regardless of previous dengue infection, and is designed to protect against all four dengue virus serotypes. The approval comes at a time when dengue continues to pose a significant public health challenge in India, which accounts for nearly one-third of the global disease burden. Reported dengue cases in the country have increased sharply…

YES BANK has reported a strong start to FY27, posting higher profitability, sustained business growth and improved asset quality in the first quarter ended June 30, 2026. The Bank’s net profit rose 33.7 per cent year-on-year to ₹1,071 crore, while operating profit increased 25.5 per cent to ₹1,704 crore. Net Interest Income (NII) grew 17.5 per cent to ₹2,786 crore, reflecting continued momentum in the Bank’s core lending business. Business growth remained healthy during the quarter, with total deposits rising 14.3 per cent year-on-year to ₹3.15 lakh crore, while net advances increased 18.3 per cent to ₹2.85 lakh crore. CASA…

Education company PhysicsWallah (PW) celebrated the achievements of its students in the NEET-UG 2026 examination, with several learners securing impressive All India Ranks (AIR) through its online and offline learning programmes. Among the top national performers were Ravikant Diwakar (AIR 55), Shivansh Anand (AIR 152), Divyansh Jaiswal (AIR 173) and Sakshi Kumari (AIR 192). Their performance reflects the effectiveness of PW’s flexible learning model, which combines digital learning with classroom-based coaching through its tech-enabled Vidyapeeth centres. The company also recognised the achievements of its Bengaluru students during a felicitation event held in the city. Shashank P (AIR 2197), Dhruva S…

Students from ALLEN Bengaluru have delivered an impressive performance in the NEET-UG 2026 examination, reaffirming the institute’s strong track record in medical entrance coaching. Diganth BS secured All India Rank (AIR) 64, while Shreyankh J achieved AIR 94, placing both among the country’s top 100 rank holders. The success was part of a strong overall performance by ALLEN South, with four classroom programme students featuring in the top 100. Vanisha Satish secured AIR 51, Diganth BS AIR 64, Navithana B AIR 88, and Shreyankh J AIR 94, reflecting the institute’s focus on academic excellence, structured learning and consistent mentoring. Congratulating…

LatentView Analytics Limited, a leading AI-driven analytics, data engineering and consulting company, has appointed Sonal Ramrakhiani as its Chief Executive Officer, effective July 15, 2026. She succeeds Rajan Sethuraman, who will serve as Strategic Advisor to the CEO for up to six months to ensure a smooth leadership transition. Based in the United States, Ramrakhiani will lead LatentView’s next phase of growth with a focus on expanding its presence across the Americas and Europe while strengthening the company’s AI-first strategy. She brings more than two decades of experience in technology, business transformation and market expansion, having most recently led Wipro…

Godrej Agrovet Limited has appointed Gaurav Pande as the Chief Executive Officer of Creamline Dairy Products Limited, marking a significant step in the company’s strategy to strengthen its leadership in South India’s dairy market. In his new role, Pande will focus on accelerating business growth, driving innovation, enhancing consumer engagement and expanding the reach of the Godrej Jersey brand across key markets. Creamline Dairy Products, one of South India’s leading private dairy companies, has built a strong presence across Andhra Pradesh, Telangana, Tamil Nadu and Karnataka through its integrated dairy value chain. The company offers a wide range of dairy…

Cube Highways Trust (“Cube InvIT”) [NSE/BSE: CUBEINVIT/543899], managed by Cube Highways Fund Advisors Private Limited, has announced the price band for its Initial Public Offering (IPO) as it prepares to transition from a privately listed Infrastructure Investment Trust (InvIT) to a publicly listed InvIT. The price band for the offer has been fixed at ₹151 to ₹152 per unit. The IPO comprises an Offer for Sale of up to ₹5,000 crore. The issue will open for subscription on Wednesday, July 22, 2026, and close on Friday, July 24, 2026. Investors, other than Anchor Investors and Strategic Investors, can bid for…